drug

Isentress

Marketedupdated 3mo ago

by $MRK Merck & Co., Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Isentress

phase2Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipientscompletedn=14
phase4Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patientscompletedn=31

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 7m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Isentress

Marketedupdated 3mo ago

by $MRK Merck & Co., Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Isentress

phase2Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipientscompletedn=14
phase4Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patientscompletedn=31

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 7m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Isentress

all catalysts(0)

Trials studying Isentress

News(0)

Report a data issue

comments(0)

Isentress

all catalysts(0)

Trials studying Isentress

News(0)

Report a data issue

comments(0)